C-CAMP along with CARB-X is delighted to bring you a new public engagement initiative, AMR Conversations, a series of open discussion sessions with academics, innovators, startups, industry, investors and policymakers, on relevant topics in Antimicrobial Resistance (AMR) and the global fightback efforts against this growing threat.
The first in this series is on India: A potentially preferred Clinical Research Partner. The session will delve into how India with a billion-plus population and a diversity like no other country, is fast emerging as the preferred Clinical Research destination the world over.
Speakers: Dr Taslimarif Saiyed, C-CAMP CEO & Director, Dr Kavita Singh, Director, DNDi, Dr Anand Anandkumar, Co-Founder & CEO, Bugworks
Date & Time: Tuesday, 7th June, 2022, 11am
Register: https://t.co/GNGNDBCGSv
To also be live streamed on C-CAMP Youtube Channel - https://www.youtube.com/c/CCAMPBangaloreStreams
